EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Sung Bo Chem (003080) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Sung Bo Chem KRW 1,824, price KRW 2,210, upside -17.5%, quality 49 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Basic Materials · KR · ISIN KR7003080009

SB Thin data Sep 24, 2026

Sung Bo Chem

003080 · KO

Weak valuationQuality is weak on top of the rich price.

!Fair value 1,824 KRW · Overvalued (−17%)
!Quality 49/100
!Expensive Growth (revenue 5y +4.5 %/yr)
!Loss over the last twelve months · -5.3% net margin (TTM) · fiscal year 2025 53.6%
!Low debt · negative free cash flow
·9.28% dividend yield
!Trails peers (2/9)
!Narrow moat 28/100
!Evidence only low, so the estimate is less certain
!Weak on valuation: 10 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

4,428 KRW 2,045 KRW Fair Value 1,824 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 2,045 KRW – 4,428 KRW · fair‑value band 1,253 KRW – 2,415 KRW · the 2,210 KRW price screens above the 1,824 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Sung Bo Chem in your weekly email

Every Wednesday you see whether Sung Bo Chem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

SBSUNGBO Co., Ltd. provides crop protection products for the agricultural industry in South Korea. The company was formerly known as Sung Bo Chemicals Co., LTD and changed its name to SBSUNGBO Co., Ltd. in April 2025. SBSUNGBO Co., Ltd. was founded in 1961 and is headquartered in Seoul, South Korea.

Stock analysis

Sung Bo Chem (003080) currently trades at 2,210 KRW, while our model-based Fair Value estimate is 1,824 KRW, implying the stock looks roughly 21.2% overvalued today.

Show more

Valuation

Bull case: the Economic Profit group reads highest at a median of 14,759 KRW per share, and 8 of the 8 models we run sit above the 2,210 KRW price.

Bear case: the Asset-Based group reads lowest at 5,255 KRW, and 0 of the 8 models stay below the price. Evidence for this calculation is low.

Scenario range: 1,253 KRW (bear) to 2,415 KRW (bull), the price of 2,210 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 49/100 (below-average quality), in the Basic Materials sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Sung Bo Chem reported revenue of 64.3B KRW in FY2025 versus 57.7B KRW in FY2021, a compound +2.8%/yr. Reported net income was 34.5B KRW in FY2025, compounding +124.3%/yr from FY2021.

Key figures

Market cap 43.3B KRW (≈ $31.8M) · P/S ratio 0.90 · Dividend yield 9.3% · Net margin 53.6% · Return on equity −1.7% · Return on assets (EBIT) −0.6% · Operating margin 15.9% · Revenue (TTM) 47.8B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 22% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at 10% fair-value upside, at −17%, 003080 screens richer than that median.

Fair Value models

Bear 1,253 KRW Fair Value 1,824 KRW Bull 2,415 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Owner Earnings 16,312 KRW 23,208 KRW 32,449 KRW 77
Growth-Adj P/E 16,625 KRW 23,750 KRW 30,875 KRW 67
Graham-Dodd 11,960 KRW 24,867 KRW 31,435 KRW 66
All 8 models by family
DCF Models
Owner Earnings 16,312 KRW 23,208 KRW 32,449 KRW 77
Earnings-Based
Graham-Dodd 11,960 KRW 24,867 KRW 31,435 KRW 66
Multiples
P/E Multiple 22,425 KRW 29,900 KRW 37,375 KRW 63
P/S Multiple 3,695 KRW 4,927 KRW 6,158 KRW 58
P/B Multiple 17,647 KRW 23,529 KRW 29,411 KRW 55
Asset-Based
NCAV (Graham) 3,921 KRW 5,255 KRW 7,843 KRW 54
Economic Profit
Residual Income 11,057 KRW 14,759 KRW 63,638 KRW 64
Growth Earnings
Growth-Adj P/E 16,625 KRW 23,750 KRW 30,875 KRW 67

Open the full fair value analysis →

Notify me when 003080 reaches fair value

Put 003080 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 49/100

Of which business quality 48 · Market factors (momentum, volatility) 45

Profitability 58
Margins and returns on capital today
Quality Growth 51
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 50
Balance sheet, leverage, solvency risk
Investment 70
Disciplined investing over empire-building
Low Volatility 96
Calm price path (market factor)
Momentum 26
Price trend over the last 3–12 months (market factor)
52W Momentum 18
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 36/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+7.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.5%
Start year 2020 (pandemic). Over 10 years: +1.4% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.2%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ +100.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+91.0%
Dividend (yield on the price)9.3%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−7% → −13%
⚠ Approximate: the rate leans on 2025, which sits 1,206% above its own trend.

003080 screens 21% overvalued. Compare with Corteva, Inc →

Compare Sung Bo Chem with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Agricultural Inputs · 179 stocks

Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 49 · Below median
Fair Value upside −18% · Below median
Profitability
Return on assets −1% · Bottom 25%
Net margin (TTM) −5% · Bottom 25%
Operating margin (TTM) 16% · Top 25%
Growth and dividend
Revenue growth −1% · Below median
Dividend yield (TTM) 9.3% · Top 25%
Balance sheet
Debt / equity 0.29× · Highest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)10 · sector 19
FUTURE (revenue growth)0 · sector 35
PAST (return on equity)0 · sector 24
HEALTH (low debt)86 · sector 97
DIVIDEND (yield)100 · sector 41

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Agricultural Inputs stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Corteva, Inc CTVA $80.34 $28.49 −65%
Nutrien Ltd NTR $75.13 $82.61 +10%
Qinghai Salt Lake Industry Co 000792 ¥24.87 ¥27.36 +10%
CF Industries Holdings CF $120.64 $161.00 +33%
SABIC Agri-Nutrients Company 2020 124.00 SAR 150.65 SAR +21%
Yara International ASA YAR kr 446.70 kr 659.87 +48%
Yunnan Yuntianhua Co 600096 ¥27.95 ¥50.49 +81%
The Mosaic Company MOS $24.73 $25.77 +4%
Asia-potash International Investment (Guangzhou)Co.,Ltd., 000893 ¥39.75 ¥38.01 −4%
ICL Group ICL $5.40 $2.98 −45%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Sung Bo Chem Fair Value". https://www.fairvalue-calculator.com/stock/003080

Frequently asked questions

Is Sung Bo Chem (003080) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 1,824 KRW versus a price of 2,210 KRW, about −17% upside (overvalued).
What is the fair value of 003080?
Our model-based fair value for Sung Bo Chem is 1,824 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 2,210 KRW.
What is the quality score of 003080?
Sung Bo Chem has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Sung Bo Chem (003080)?
Our model-based price target is the fair value of 1,824 KRW (as of Sep 24, 2026) from 8 valuation models. Cautious scenario 1,253 KRW, optimistic scenario 2,415 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Sung Bo Chem stock forecast for 2026?
Our models put fair value at 1,824 KRW, about −17% upside versus a price of 2,210 KRW (overvalued). Cautious scenario 1,253 KRW, optimistic scenario 2,415 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Sung Bo Chem (003080)?
Sung Bo Chem reported trailing-twelve-month revenue of about 47.8B KRW (latest available figure, as of Sep 24, 2026).
Does Sung Bo Chem pay a dividend?
Sung Bo Chem currently shows a dividend yield of about 9.28% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Sung Bo Chem (003080)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Sung Bo Chem it is 1,824 KRW per share (as of Sep 24, 2026), against a price of 2,210 KRW. It is the blended result of 8 valuation models (cash flow, earnings, asset, dividend).
Is Sung Bo Chem stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 003080 trades above its calculated fair value: price 2,210 KRW, fair value 1,824 KRW, a gap of about −17% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 003080?
No. The price is what the market pays today (2,210 KRW); the fair value is what the company's own numbers justify (1,824 KRW). For Sung Bo Chem the two are 385.76 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Sung Bo Chem worth?
The market values Sung Bo Chem at about 43.3B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 2,210 KRW; our models calculate a fair value of 1,824 KRW per share.
What do the bullish and bearish scenarios say about 003080?
Our models span a range for Sung Bo Chem: cautious scenario 1,253 KRW, base 1,824 KRW, optimistic 2,415 KRW per share (as of Sep 24, 2026, price 2,210 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Sung Bo Chem (003080)?
Balance-sheet figures for Sung Bo Chem (as of Sep 24, 2026): return on equity −1.7%, debt of 0.29 per unit of equity. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is 003080 from its 52-week high?
Sung Bo Chem trades at 2,210 KRW, about 22% below its 52-week high of 2,820 KRW and 8% above the low of 2,045 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 1,824 KRW is for.
Which stocks are comparable to Sung Bo Chem?
From the same area (Basic Materials) we also value Corteva, Inc, Nutrien Ltd, Qinghai Salt Lake Industry Co, CF Industries Holdings, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Sung Bo Chem stock attractive at the current price?
The data as of Sep 24, 2026: price 2,210 KRW, calculated fair value 1,824 KRW (−17%), Quality Score 49/100, from 8 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 003080 calculated?
We run Sung Bo Chem through 8 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1,824 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Sung Bo Chem itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Sung Bo Chem (003080)?
The closing price on Sep 23, 2026 was 2,210 KRW. Our model-based fair value is 1,824 KRW, about −17% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Sung Bo Chem right now?
Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range (1,253 KRW to 2,415 KRW) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Sung Bo Chem

How large is the market capitalisation of Sung Bo Chem (003080)?
The market capitalisation of Sung Bo Chem is 43.3B KRW (≈ $31.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Sung Bo Chem (003080)?
The price-to-sales ratio of Sung Bo Chem is 0.90 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Sung Bo Chem (003080)?
The dividend yield of Sung Bo Chem is 9.3%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Sung Bo Chem (003080)?
The net margin of Sung Bo Chem is 53.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Sung Bo Chem (003080)?
The return on equity (ROE) of Sung Bo Chem is −1.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Sung Bo Chem (003080)?
On an EBIT basis the return on assets of Sung Bo Chem is −0.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Sung Bo Chem (003080)?
The operating margin of Sung Bo Chem is 15.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Sung Bo Chem (003080)?
Revenue at Sung Bo Chem is growing −1.3% versus a year earlier (3y avg −1.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Sung Bo Chem (003080)?
Earnings per share at Sung Bo Chem are growing −12.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Sung Bo Chem (003080) generate?
The free cash flow of Sung Bo Chem is −9.8B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Sung Bo Chem (003080) carry?
The net debt of Sung Bo Chem is 27.7B KRW (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Sung Bo Chem in the live analysis

One click puts Sung Bo Chem on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.